Insect-borne parasites undergo life-cycle differentiation to adapt to rapid changes in temperature[@R1],[@R2], nutritional-availability[@R3] and potential immunological-attack[@R4] as they enter their arthropod vector. The cues that induce such changes are often well characterised, such as temperature reduction and pH changes[@R5] or exposure to arthropod-derived factors[@R6]. However, the surface molecules that transmit these signals and initiate intracellular differentiation events in microbial parasites are often not well characterised.

African trypanosomes are protozoan parasites responsible for fatal disease in humans and livestock in sub-Saharan Africa, generating significant restrictions in health and welfare in afflicted regions[@R7]. The transmission of these parasites by tsetse flies requires the development of bloodstream 'stumpy-forms', a G0-arrested cell-type pre-adapted for transmission[@R8]-[@R10]. Stumpy-forms arise via quorum-sensing from proliferative 'slender-forms' at the peak of each parasitaemia in response to an unidentified parasite-derived signalling factor, stumpy induction factor (SIF)[@R11]. Although the morphological extremes of slender and stumpy-forms are easily distinguished, the development from slender- to stumpy-morphology is progressive[@R12], with transitional forms loosely described as 'intermediates'. To date, no developmentally-regulated surface marker has been identified that discriminates slender and stumpy-cells.

When ingested by tsetse during a bloodmeal, slender-forms are killed whereas stumpy-forms differentiate to procyclic-forms[@R13]. Bloodstream trypanosomes can also be induced to differentiate in vitro by the Krebs-cycle intermediates, citrate or *cis*-aconitate (CCA)[@R14]. Recently, it was discovered that temperature reduction from 37°C to 20°C could induce hypersensitivity of stumpy-forms to CCA[@R2], such that differentiation was induced at concentrations found in the tsetse (15.9μM^[@R15]^) or ingested blood-meal (\~130μM^[@R16]^). This probably represents a natural condition in the trypanosome life-cycle, since tsetse are exposed to cool conditions when feeding at dusk or early morning[@R2]. Nonetheless, the molecule responsible for the transmission of the CCA differentiation signal has remained unidentified.

PAD family identification and expression {#S1}
========================================

We previously selected a trypanosome line (DiD1, Defective in Differentiation-1) with reduced ability to differentiate to procyclic forms[@R10]. The expression profile of DiD1 was compared with its differentiation-competent parent by differential hybridization of labelled cDNA to genomic arrays. This identified 2 adjacent genes on chromosome 7 of the *T.brucei* genome (Tb927.7.5930 and Tb927.7.5940), there being a stronger signal with DiD1-derived cDNA compared to the parental. These genes comprise the first two genes in an 8-gene array at the end of a unidirectional gene cluster (named the 'PAD' gene array, for 'Proteins Associated with Differentiation'; see below) (Supplementary Fig. 1a). Although no mutation in either gene was detected (Supplementary Fig. 2), northern blotting confirmed the differential expression of both *PAD1* and *PAD2* genes in the DiD1 line ([Figure 1a](#F1){ref-type="fig"}). Further, *PAD1* and *PAD2* mRNA showed stage-regulated expression, *PAD1* being enriched in stumpy-forms, whereas *PAD2* was elevated in procyclic-forms. Neither *PAD1* nor *PAD2* mRNA was significantly expressed in slender-forms ([Figure 1a](#F1){ref-type="fig"}).

The *PAD* genes encode closely-related members of a family of 14 transmembrane-spanning proteins of the major facilitator superfamily ([Figure 1b](#F1){ref-type="fig"}; Supplementary Fig. 1b). PSI-BLAST searches revealed a conserved domain in plant nodulin-like proteins (PF06813) and closest overall similarity to carboxylate transporters. Supporting this, *Xenopus* oocytes microinjected with cRNA encoding either PAD1 or PAD2 showed a marked increase in the uptake of ^14^C citrate relative to non-injected controls ([Figure 1c](#F1){ref-type="fig"}).

An antibody detecting all members of the PAD protein family reacted with distinct bands in different trypanosome life-cycle stages ([Figure 1d](#F1){ref-type="fig"}); although there was no significant expression in slender-forms, stumpy-forms exhibited two prominent bands at 55kDal and 57kDal, whereas procyclic-forms predominantly expressed the 57kDal band. Neither corresponded to the predicted size of any PAD protein, probably because proteins with extensive transmembrane regions frequently migrate aberrantly. Specific anti-peptide antibodies showed that the 55kDal and 57kDal bands corresponded to PAD1 and PAD2 respectively, and that PAD1 was stumpy-form specific, whereas PAD2 was expressed 6-fold more in procyclic-forms than stumpy-forms ([Figure 1d](#F1){ref-type="fig"}). During synchronous differentiation from stumpy- to procyclic-forms, PAD1 was retained only during the first 24h, whereas PAD2 was strongly induced during this period (up to 17-fold at 24h; Supplementary Fig. 3).

PAD1 marks the transmissible stumpy form {#S2}
========================================

The PAD1 expression profile suggested that it might provide a useful cytological marker for stumpy-forms. To investigate this, the location and expression of PAD1 was analysed in mixed populations of slender and stumpy-forms. [Figure 2a (left two panels)](#F2){ref-type="fig"} shows immunofluorescence images demonstrating stumpy-specific expression of PAD1. Confocal images ([Figure 2a, right panel](#F2){ref-type="fig"}) demonstrated an intense staining at the stumpy-cell periphery, revealing surface membrane labelling. To quantitate the stumpy-specific expression of PAD1, 'intermediate' cell populations were assayed with PAD1 and counterstained with DAPI, allowing their cell-cycle position to be determined. In trypanosomes, cells in G1/G0 and S-phase have 1 kinetoplast and 1 nucleus (1K1N), whereas G2/M and post-mitotic cells have a 2K1N or 2K2N DNA configuration, respectively[@R17]. Since stumpy-forms are uniformly arrested in G1/G0[@R18], 2K1N or 2K2N cells can be unambiguously assigned as slender-forms. Detailed examination of cells within each category of 1K1N, 2K1N or 2K2N (an overall analysis of \>10,000 cells) demonstrated that dividing-cells and cells with a slender morphology were overwhelmingly negative for PAD1 ([Figure 2b](#F2){ref-type="fig"}). However, \~10% of 1K1N and 2K2N slender-cells were PAD1-positive: these may represent 'intermediate' cells that have committed to stumpy-formation.

To investigate whether only the PAD1-positive bloodstream trypanosomes were competent to differentiate to procyclic-forms, mixed populations of slender and stumpy-forms were examined 6 hours after exposure to *cis*-aconitate (CA) for EP-procyclin expression, an early marker for differentiation[@R19]. This confirmed a precise correspondence between EP-procyclin and PAD1 expression, with 96% of cells showing matching staining for both markers ([Figure 2c,d](#F2){ref-type="fig"}). Thus, PAD1 identifies stumpy-forms in a bloodstream population as those competent to differentiate to procyclic forms.

PAD2 is thermoregulated {#S3}
=======================

As surface carboxylate transporters expressed on stumpy forms, PAD proteins were good candidates as transducers of the CCA-developmental signal. To evaluate this, we initially tested the inducibility of PAD proteins at 20°C, a predicted requirement for physiological CCA-sensitivity[@R2]. This revealed that PAD2 was consistently up-regulated \~4-fold (range 3-32 fold) at 20°C. Analysing two trypanosome strains (*T. brucei* AnTat 1.1 and *T. brucei* EATRO 2340) demonstrated 4-fold and 3.8-fold up-regulation of PAD2, respectively, at 20°C when compared to 37°C ([Figure 3a](#F3){ref-type="fig"}). In contrast, PAD1 expression was unaltered. This eliminated the possibility that the elevation of PAD2-expression was due to general enhancement of membrane protein expression at low-temperature. Other stress conditions such as pH or cell concentration did not affect PAD2 expression (Supplementary Fig. 4 and data not shown). Interestingly, at 37°C PAD2 was predominantly at the flagellar pocket, whereas it was surface located at 20°C ([Figure 3b, c](#F3){ref-type="fig"}), this redistribution occurring within 60 min (Supplementary Fig. 5). Thus, PAD2 is a novel example of both a thermoregulated parasite molecule[@R1] and a transmembrane protein exhibiting regulated surface distribution[@R20].

PAD proteins convey the CCA differentiation signal {#S4}
==================================================

To functionally test PAD proteins in CCA-initiated differentiation, a gene fragment with \>95% identity between each *PAD* gene was targeted by RNAi, enabling simultaneous knock-down of all members. This was performed in the pleomorphic *T. brucei* AnTat 90:13 line[@R2] that generates stumpy-forms at high frequency, exhibits cold-sensitivity to CCA and has been engineered for doxycycline-inducible RNAi-mediated transcript ablation. The resulting transgenic cell-line, in parallel with the parental line, was grown in mice ±doxycycline induction for 6 days, each producing \>80% stumpy populations (Supplementary Fig. 6). Although the RNAi effect was considerably leaky, there was 80% depletion of PAD proteins in the RNAi-induced cells ([Figure 4a](#F4){ref-type="fig"}), demonstrating that significant PAD expression was not required for either stumpy formation or survival (Supplementary Fig. 6). Once the transgenic stumpy-forms were harvested from blood and incubated for 16h at 20°C, they were exposed to different concentrations of CA and differentiation monitored by EP-procyclin expression. Cells incubated at 20°C exhibited the expected cold-induction of EP-procyclin expression[@R2] although this was consistently and inducibly reduced in the RNAi line ([Figure 4b](#F4){ref-type="fig"}, "0h CS" samples). This may indicate some interaction between PAD and EP-procyclin surface expression similar to mammalian monocarboxylate transporters, which co-associate with single-pass membrane proteins for surface access and activity[@R21]. Most significantly, however, PAD-depletion reduced the differentiation of cells exposed to CA, with this being more effective at 20°C (F~1,44~=16.82, p\<0.0005 at 6h) than 37°C (F~1,44~=6.60, p\<0.014). Indeed, at 0.1mM CA there was a 70% reduction of EP-procyclin expression compared to the control line at 6h, this expression being further reduced over 24h due to reversal of cold-induction at 27°C ([Figure 4C](#F4){ref-type="fig"}; Supplementary Fig. 7). Matching the response to CA, PAD RNAi also diminished the response of stumpy cells to citrate at 20°C (Supplementary Fig. 8). A cell-line specific differentiation-defect unrelated to PAD RNAi was eliminated by transiently-transfecting pleomorphic cells with the RNAi construct, this recapitulating the differentiation phenotype (Supplementary Fig. 9). Moreover, the RNAi lines differentiated as well as parental cells in response to pronase treatment, an alternative differentiation trigger (Supplementary Fig. 10)[@R15]. Hence, ablating PAD mRNAs reduced overall differentiation responses to CCA at all concentrations tested but specifically abrogated the cold-induced CCA-hypersensitivity of stumpy-forms.

Conclusions {#S5}
===========

These experiments demonstrate that the PAD proteins act as transducers of the CCA differentiation signal in *Trypanosoma brucei*. This conclusion is based on several lines of evidence: (i) PAD proteins are surface molecules expressed on stumpy-forms but absent in transmission-incompetent slender-forms (ii) at the single-cell level, PAD protein expression correlates precisely with the differentiation capacity of bloodstream-form parasites (iii) at least one PAD protein (PAD2) demonstrates cold-regulated expression and localisation, consistent with predictions for the reception of the CCA signal in vivo and (iv) depletion of PAD protein expression in pleomorphic trypanosomes reduces their competence for differentiation and eliminates CCA-responsiveness at physiologically-relevant concentrations. In laboratory-adapted monomorphic slender trypanosomes, which do not express detectable levels of PAD proteins but which can differentiate in response to CCA, signalling is likely driven through other transporters by the high concentrations of CCA required for differentiation in these cell lines[@R14]. Consistent with this, incubating monomorphic slender forms, *T. brucei* AnTat 1.1 90:13 stumpy forms and the PAD RNAi stumpy forms with ^14^C citrate revealed a clear correlation between PAD expression and cell-associated label (Supplementary Fig. 11). All of these characteristics are compatible with current models for the reception of the signal to differentiation from bloodstream to procyclic-forms[@R8], with the relay of the CCA signal by PAD proteins providing the first molecular insight linking environmental-sensing to trypanosome cell-type differentiation. Notably, this does not exclude an additional or complementary role of proteases in the tsetse midgut, which can act with CCA to promote robust differentiation[@R22].

The identification of PAD1 as a stumpy-specific surface marker protein also provides two key advances. Firstly, the precise correlation between PAD1 expression and differentiation-capacity directly confirms stumpy-forms as the essential transmissible-stage in the bloodstream, supporting classical observations[@R23] but contrasting with some recent models[@R24]. Secondly, the discovery of PAD1 permits the quantitative modelling of trypanosome population dynamics in chronic infections[@R25] and the development of bioassays to detect stumpy-formation. This has obvious application for monitoring the activity of the signal for quorum-sensing, SIF, and in high-throughput screens for therapeutic agents that promote stumpy-formation and hence prevent parasite virulence.

Methods Summary {#S6}
===============

PAD RNAi constructs {#S7}
-------------------

PAD protein sequences from GeneDB were analysed using TMHMM[@R26] and displayed using TMRPres2D[@R27] to determine the position of the transmembrane helices. The PAD1 reading frame was amplified from genomic DNA by polymerase chain reaction using 5′-tttaagctttgatcaatgagcgcacccgtcgacaacgtc-3′ and 5′-aaactcgagcatatgtcattgcggagcagcctcacgggc-3′ primers, and cloned into the HindIII-XbaI and XhoI-BamHI cloning sites of pALC14[@R28] to generate the PAD RNAi plasmid.

Parasite growth and transfection {#S8}
--------------------------------

Culturing, transfection, differentiation, and cold-shock assays were performed as described[@R2],[@R29] on *T. brucei* AnTat1.1 90-13[@R2] and selected using 0.5 μg ml^−1^ puromycin. Stumpy-enriched populations were obtained by DEAE-cellulose purification[@R30] of parasites 6-7 days post-infection into cyclophosphamide-treated mice.

PAD-expression analysis {#S9}
-----------------------

Peptides specific to PAD1 (H~2~N-CPKEPTRDAREAAPQ-COOH and H~2~N-ETCCRREVAE-COOH), PAD2 (H~2~N-EAEDNQTNAENVC-COOH and H~2~N-CNADACLEEKAADSSK-COOH) and the entire array (H~2~N-VETDVDYIAPQFQET-CONH~2~ and H~2~N-TQQADKLGQDVCTER-COOH) were used to generate antipeptide antibodies (Eurogentec). Immunofluorescence analysis was performed[@R31] using a Zeiss Axioscope 2 or Leica SP5 confocal microscope and analysed using Volocity software (Improvision). Images were processed using Adobe Photoshop CS. Western blotting was performed by low-voltage SDS-PAGE and wet transfer onto Immobilon-P PVDF (Millipore) according to the manufacturer\'s instructions; proteins were detected using the LI-COR Odyssey system for quantification against a tubulin loading control. Flow cytometry analysis was performed using the FACS-Calibur flow cytometer (Becton Dickenson)[@R11].

Xenopus oocyte transport assays {#S10}
-------------------------------

PAD genes were cloned into pGHJ and radiolabelled citrate experiments were performed as described[@R32]. Uptake measurements were made over 1h in oocytes (5-days post-injection) incubated at pH 9 and 27.5°C.

Statistical analysis {#S11}
--------------------

Differentiation data were analysed using a general linear model. Residuals did not conform to a normal distribution and therefore a logarithmic transformation was used. Statistical analysis was carried out using minitab version 15, with P values of p\< 0.05 being considered statistically significant.

Methods {#S12}
=======

Trypanosomes {#S13}
------------

*Trypanosoma brucei brucei* AnTat1.1 and *Trypanosoma brucei brucei* EATRO 2340 were used. Stumpy forms were generated by 5-6 days growth in MF1 mice, treated with cyclophosphamide 24h prior to infection. Slender and monomorphic slender parasites were generated after 3 days growth in rodents.

For pleomorphic transfection, cells from an early-stage parasitaemia (3--4 days, depending on the infection) were purified from the buffy coat and the cells transfected using an AMAXA nucleofector protocol (T-cell nucleofection buffer, programme X001). Drug selection was carried out in cells maintained in HMI-9 media supplemented with 1.1% methyl cellulose at a concentration of approximately 5 × 10^6^ cell ml^−1^. Transgenic parasites were selected using 0.5 μg ml^−1^ puromycin.

Macroarray analysis {#S14}
-------------------

Expression differences between the DiD1 and parental progenitor were carried out by reverse transcription of 5μg of polyA+ RNA from each cell type, this being labelled using the GE Healthcare Gene Images non-radioactive labelling system. Macroarrays, a gift from Professor Elisabetta Ullu, Yale University, USA, comprised 15,000 plasmid clones of 1-2Kb sheared DNA (\~0.8x genome coverage) from *Trypanosoma brucei* TREU 927/4 cloned into pUC18 and arrayed in 384 microtitre dishes over 39 plates. Bacterial clones were spotted onto 22cm^2^ nylon membranes in a 4×4 array format. After hybridization, signals were detected by ECL and differential signals, obtained in duplicate, were identified and validated by northern analysis.

Western analysis of PAD proteins {#S15}
--------------------------------

Cells were resuspended at 3 × 10^6^ cells in 10 μl of Laemmli sample buffer containing β-mercaptoethanol at room temperature. Genomic DNA was then sheared by sonication and the sample placed upon ice. 10 μl of protein sample was then resolved on a 10% polyacrylamide gel at 100V at 4°C for approximately 4 hours using chilled buffers. Gels were blotted onto PVDF Immobilon-P (Millipore) at 4°C using a wet blotting system (BioRAD) with chilled buffers. For western blotting, primary antibodies were used at 1:1000 and secondary antibodies were used at 1:5000. Detection after primary antibody incubation used IRDye 680 Goat Anti-Rabbit IgG or IRDye 800CW Goat Anti-Mouse IgG, and was analysed via a Li-COR Odyssey Imager.

Immunofluorescence {#S16}
------------------

For methanol fixation to preserve the overall cell shape, cells were spread onto microscope slides, and air-dried prior to fixation in methanol at −20°C for at least 10 minutes. Cells were rehydrated in PBS for 10 minutes prior to labelling, this being carried out as for paraformaldehyde fixed cells. For paraformaldehyde fixation, 2×10^6^ cells were resuspended in 100μl vPBS (8g/l NaCl; 0.22g/l KCl; 2.27g/l Na~2~HPO~4~; 0.41g/l KH~2~PO~4~; 15.7g/l sucrose, 1.8g/l glucose; pH7.4), and then an equal volume of 6% paraformaldehyde added. After 10 minutes the suspension was diluted to 5ml in vPBS and settled onto poly-L-lysine coated slides for 20 minutes and then washed with PBS. The cells were then permeabilised in 0.05% Triton X100 for 10 minutes, blocked in 20 % foetal calf serum (FCS) in vPBS for 45 minutes, and stained with the primary antibody (1:100) in 20 % FCS in vPBS for \>1 hour.

Subsequent to washing in excess PBS, the cells were stained with the secondary antibody (1:500) in 20 % FCS: vPBS for 1 hour, washed in excess PBS 3 × 5 minutes after which the cellular DNA was stained with a 1 μg ml^−1^ 4′,6-diamidino-2-phenylindole. Cells were mounted in MOWIOL containing phenylene diamine.

Flow cytometry {#S17}
--------------

Between 2 -- 5 × 10^6^ cells were fixed in 2 % formaldehyde/ 0.05 % glutaraldehyde for a minimum of 1 hour at 4 °C. Subsequently, the cell suspension was pelleted and resuspended in 200 μl of EP procyclin antibody (Cedar Lane Laboratories) diluted 1:500 in 2 % BSA in PBS. Cells were washed twice prior to being stained with the primary antibody, washed twice and stained with the secondary antibody (1:500). Flow cytometry data were analysed using FlowJO (Tree Star Inc.) software, with unstained cells, and cells stained with only the secondary antibody providing negative controls.

Image acquisition equipment and settings {#S18}
----------------------------------------

Immunofluorescence microscopy images ([Figure 2c](#F2){ref-type="fig"}) were captured on a Zeiss axioskop 2 (Carl Zeiss microimaging, Inc.) with a Prior Lumen 200 light source using a QImaging (QImaging, Bucks, UK) Retiga 2000R CCD camera; objectives were either Plan Neofluar 63x (1.25 NA) or Plan Neofluar 100x (1.30 NA). Images were captured via QImage (QImaging, Bucks, UK) and pseudocoloured using Adobe photoshop CS. Confocal imaging ([Figure 2a](#F2){ref-type="fig"}; [Figure 3c](#F3){ref-type="fig"}) used a Leica SP5 confocal laser scanning microscope, using x63 oil immersion objective (N.A.=1.4), with 4.2x zoom. The green channel was imaged using a 488nm argon laser, the red channel was imaged using a 543nm Helium/Neon laser and the image was acquired at 1024/1024 voxels for x/y resolution with sequential optical sections of 0.54μm in z-axis increments. The image was optimised by adjusting laser power and detector sensitivity to minimise bleaching and maintain a digital signal of between 0-255 to avoid signal loss or saturation. The final image was acquired using Volocity^™^ Software (Improvision Ltd, Coventry, UK) Version 4.4.
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![Identification and characteristics of PAD proteins\
**(a)** Expression of PAD-mRNAs in DiD-1, parental slender-forms ("Sl"), stumpy-forms ("St") and procyclic-forms ("Pcf"). rRNAs show loading.**(b)** Predicted transmembrane domains in PAD1.**(a)** \[^14^C\]citrate uptake into *Xenopus* oocytes microinjected with 20 ng cRNA encoding PAD1 or PAD2, or non-injected. The data (from 8-10 oocytes, shown ± s.e.m.) are representative of ten experiments in which oocytes expressing PAD1 exhibited 1.4-3.7-fold increase in \[^14^C\]citrate uptake and oocytes expressing PAD2 exhibited 1.6-5.4-fold increase relative to non-injected controls.**(b)** Expression of PAD proteins in slender-, stumpy- and procyclic-forms normalised to α-tubulin. The PAD2-antibody cross-reacts weakly with the 60kDal VSG in slender-forms.](ukmss-4281-f0001){#F1}

![PAD1 identifies stumpy forms\
**(a)** PAD1-expression on methanol-fixed trypanosomes. The slender-cell ('sl'; identified by having two kinetoplasts, arrowed in the DAPI panel) is PAD1-negative, the stumpy-cell ('St') is PAD1-positive. A confocal image of a paraformaldehyde-fixed stumpy-form is also shown (right); peripheral PAD1-labelling (green) is arrowed; nucleus, 'n', and kinetoplast, 'k', (both stained blue).**(b)** Quantitation of PAD1 expression on different cell-cycle stages.**(c)** PAD1-positive cells are those competent to differentiate. Slender and stumpy-forms were methanol-fixed 6hr through differentiation. A slender-morphology PAD1-negative, EP-Procyclin-negative cell is arrowed, other cells are PAD1-positive (red), EP-procyclin-positive (green). Phase-contrast and DAPI images are also shown.**(d)** Quantitation of the cells expressing PAD1 and/or EP-procyclin. n=500.](ukmss-4281-f0002){#F2}

![PAD2 is cold-inducible\
**(a)** PAD protein expression at 37°C or 20°C in stumpy-forms of *T. brucei* EATRO 2340 or *T. brucei* AnTat1.1. Samples were stained for all PAD proteins ("Array"), PAD1 or PAD2. α-tubulin controlled for loading.**(b)** Confocal immunofluorescence-images of paraformaldehyde-fixed stumpy-forms incubated at 37°C or 20°C and co-labelled for α-tubulin (red), PAD2 (green) and DAPI (blue). At 37°C, PAD2 predominantly localised to the flagellar pocket (f.p.; arrowed); at 20°C PAD2 located at the cell surface.**(c)** Quantitation of the PAD2 location at 37°C or 20°C.](ukmss-4281-f0003){#F3}

![RNAi against all PAD genes reduces differentiation\
**(a)** PAD-array expression in parental or PAD-RNAi lines (±doxycycline, D+, D) after 16h at 20°C. Tubulin, loading control.**(b)** EP-procyclin in Parental ('P') and PAD-RNAi stumpy-forms grown ±doxycycline (D+, D−) after 16h at 20°C, then incubated at 27°C with a CA titration. Means (±s.e.m.) of three experiments are shown, as is the % reduction in EP-procyclin in the PAD-RNAi cells compared with parental cells.**(c)** Flow-cytometry of EP-procyclin expression in PAD-RNAi or parental cells incubated with 0.1mM or 1mM CA. Cold-induced hypersensitivity to CA is ablated in the PAD-RNAi line; at ≥1mM CA both populations differentiate, although this is reduced in the RNAi line. Full flow cytometry data are available in Supplementary Fig. 7.](ukmss-4281-f0004){#F4}
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